TerrAscend Corp. (OTCMKTS:TSNDF) Short Interest Update

TerrAscend Corp. (OTCMKTS:TSNDF) saw a large growth in short interest in March. As of March 15th, there was short interest totalling 2,621,900 shares, a growth of 53.8% from the February 28th total of 1,704,200 shares. Based on an average daily trading volume, of 1,976,300 shares, the days-to-cover ratio is currently 1.3 days. Approximately 1.3% of the shares of the company are short sold.

Wall Street Analysts Forecast Growth

Separately, Atb Cap Markets cut shares of TerrAscend from a “strong-buy” rating to a “hold” rating in a research note on Monday, December 9th.

TerrAscend Trading Up 3.2 %

Shares of TSNDF stock opened at $0.49 on Monday. The company has a current ratio of 1.35, a quick ratio of 0.69 and a debt-to-equity ratio of 0.81. TerrAscend has a 12-month low of $0.38 and a 12-month high of $2.20. The stock has a market capitalization of $142.16 million, a P/E ratio of -1.73 and a beta of 1.64. The firm’s 50 day moving average is $0.52 and its 200 day moving average is $0.77.

TerrAscend (OTCMKTS:TSNDF) last announced its earnings results on Thursday, March 6th. The company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.03) by $0.04. TerrAscend had a negative return on equity of 31.48% and a negative net margin of 23.95%. The business had revenue of $74.35 million for the quarter, compared to analysts’ expectations of $72.37 million. Research analysts expect that TerrAscend will post -0.14 earnings per share for the current year.

TerrAscend Company Profile

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.